Diltiazem Hydrochloride Capsule, Extended Release
Product Images NDC 70518-3484

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Diltiazem Hydrochloride (NDC 70518-3484). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

This is a description of a medication called DilTIAZem HCI, which is an extended-release capsule with a strength of 120 mg. The package contains 30 capsules and is a prescription-only medication. The lot number and expiration date are not visible, but the source NDC is 50742-0248-90, and the manufacturer is Ingenus based in Fairfield, NJ. The medication should be stored at 20-25°C (88-77°F), with excursions allowed up to 15-30°C (59-86°F), and kept out of reach of children. The packaging was done by RemedyRepack Inc. based in Indiana, PA. Directions for use can be found in the package insert.*

FDA Label Image

Image (Image 01)

FDA Label Image

Image (Image 02)

This is a description of a clinical study which compares the use of extended-release capsules of Diltiazem hydrochloride with placebo in treating angina and hypertension. The study reports the adverse reactions experienced by patients using Diltiazem hydrochloride, such as headaches, dizziness, bradycardia, AV block, edema, and asthenia, and compares them to the reactions experienced by patients under placebo.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.